Clinical use of rituximab in haematological malignancies.
about
Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disordersA seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohortsIntraocular lymphoma: update on diagnosis and management.Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.Cancer vaccines: a clinical perspective.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesUpdate on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.Rituximab (Rituxan).Rituximab and minimal change nephrotic syndrome: a therapeutic option.Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy.An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients.
P2860
Q28280510-3349B573-1481-4C3A-9765-51ABEC47BC29Q28728722-E2F867E3-B3CA-4106-A870-F20AC894D25BQ35892007-807EF878-D53E-46BE-8E55-8D12109711BCQ36079223-DD195616-9A3C-4562-A929-9C95B3A439AFQ36554683-FAE5D9B4-59B2-458F-9D26-51EB9F5F8C6BQ36724093-92C77AF5-3A61-4413-93A6-6ACB11C31FC4Q36879135-EBCEE4C4-C3B5-49C1-91C2-9BCE7D4280C2Q37744225-EC6CA214-D4F7-4200-8BBD-162F9E0A5BAFQ37879578-E07ADB22-984D-483E-AA47-CFD6FC7F4FCAQ40600575-14BEE199-4153-4ECB-B42F-123FFF803645Q41760763-0FD876D1-9B5C-4562-B00A-5D9E2FC5BAC0
P2860
Clinical use of rituximab in haematological malignancies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Clinical use of rituximab in haematological malignancies.
@ast
Clinical use of rituximab in haematological malignancies.
@en
type
label
Clinical use of rituximab in haematological malignancies.
@ast
Clinical use of rituximab in haematological malignancies.
@en
prefLabel
Clinical use of rituximab in haematological malignancies.
@ast
Clinical use of rituximab in haematological malignancies.
@en
P2093
P2860
P921
P356
P1476
Clinical use of rituximab in haematological malignancies.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601187
P407
P577
2003-10-01T00:00:00Z
2003-10-20T00:00:00Z